Latest Series A Funding Rounds

Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.

This page showsStage: Series A
Rounds
1,140
All time
Disclosed funding
$47.7B
980 disclosed amounts
Median round
$20M
Of disclosed amounts
1,140 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
TucuviAI · SpainCompany profile

Tucuvi provides conversational AI for clinical patient follow-up and monitoring.

Tucuvi provides conversational AI for clinical patient follow-up and monitoring.

$20MSeries AAISpainInvestors
Spangle AIAI · United StatesCompany profile

Builds agentic infrastructure layer connecting AI-led discovery to real-time conversion for commerce

Builds agentic infrastructure layer connecting AI-led discovery to real-time conversion for commerce

$15MSeries AAIUnited StatesInvestors
Enhanced Digital Group Inc.Fintech · United StatesCompany profile

Provides derivatives solutions in the digital asset space for institutional clients

Provides derivatives solutions in the digital asset space for institutional clients

UndisclosedSeries AFintechUnited StatesInvestors
VizgenBiotech · United StatesCompany profile

Builds technologies for spatial biology and multi-omics innovation

Builds technologies for spatial biology and multi-omics innovation

$48MSeries ABiotechUnited StatesInvestors
BrightHeartAI · FranceCompany profile

BrightHeart develops AI software for prenatal ultrasound and fetal-heart screening.

BrightHeart develops AI software for prenatal ultrasound and fetal-heart screening.

€11MSeries AAIFranceInvestors
Poplar TherapeuticsHealthtech · United StatesCompany profile

Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions

Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions

$50MSeries AHealthtechUnited StatesInvestors
Prudentia SciencesBiotech · United StatesCompany profile

Provides AI-native due diligence for life sciences dealmaking

Provides AI-native due diligence for life sciences dealmaking

$20MSeries ABiotechUnited StatesInvestors
Spiro MedicalHealthtech · United StatesCompany profile

Develops a Pulmonary Neuromodulation System for asthma treatment

Develops a Pulmonary Neuromodulation System for asthma treatment

$67MSeries AHealthtechUnited StatesInvestors
Corsera HealthHealthtech · United StatesCompany profile

Develops preventive RNAi medicines for cardiovascular disease prediction and prevention

Develops preventive RNAi medicines for cardiovascular disease prediction and prevention

$80MSeries AHealthtechUnited StatesInvestors
ArenaAI · United StatesCompany profile

Arena evaluates AI models through comparisons and observations of how people use them in real tasks.

Arena evaluates AI models through comparisons and observations of how people use them in real tasks.

$150MSeries AAIUnited StatesInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    Y Combinator (YC)

    Palomma, Easol, Vera Health

    56rounds
    0led
  2. 2
    Andreessen Horowitz (a16z)

    Larridin, Eka Robotics, TypeSafe AI

    35rounds
    10led
  3. 3
    General Catalyst

    Onodrim Industries, Hyperbolic, Baba

    28rounds
    2led
  4. 4
    Accel

    Humyn Labs, Dreamteam, SE3

    25rounds
    8led
  5. 5
    Alumni Ventures

    Larridin, Chariot Claims, RegCell, Inc.

    24rounds
    0led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic